Evergreen Clinical Trials

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Migraine1 trial
• Type 2 diabetes1 trial

Phase

• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Cleerly, Inc.1 trial
• TriGemX Bio, Inc.1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Dmitriy Pelishev

• Recruiting

  A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  NCT06112418· Cleerly, Inc.· Source

  Contact: Dmitriy Pelishev, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Migraine1 recruiting
• Type 2 diabetes1 recruiting